Fl
Flatiron Health (Roche)
New York NYFounded 2012600 employees
Private CapbiotechAcquiredOncology
Platform: Oncology RWD
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niramavacamten | FLA-7637 | Preclinical | 1 | Cl18.2 | ALS | ||
| FLA-5216 | FLA-5216 | Approved | 4 | CD47 | CMLMeso |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)